Sandy Alcantara Yankees Speculation Intensifies Following MLB Insider Verdict On New York

The buzz surrounding Sandy Alcántara and the New York Yankees is heating up again, as recent reports suggest the Bombers might have a “legitimate shot” at acquiring the former Cy Young winner. With their rotation thinner than expected this season — especially after injuries and losses in pitching depth — New York appears increasingly motivated to target a high-upside arm.

Alcántara, once among the game’s most dominant starters, remains under team control through 2027 (with a club option for 2027) — a rare commodity for a pitcher of his pedigree. That contract control, combined with his previous track record and upside if he fully bounces back post‑Tommy John surgery, makes him a tempting target for the Yankees as they hunt for more stability in the rotation.

Still, the path toward a trade isn’t smooth. The biggest holdup: the price. The Miami Marlins reportedly value Alcántara highly, and proposals suggest they’re asking for top prospects in exchange — including names the Yankees may be reluctant to part with. Critics say New York’s depleted farm system makes it hard to offer a return that satisfies Miami without mortgaging long-term potential.

There’s also the risk factor: Alcántara’s 2025 season has been rocky. After coming off Tommy John surgery, his performances have been inconsistent — raising legitimate concerns about his ability to return to elite form. For the Yankees, this means trading youth and upside for a possible rebound — a calculated gamble, but a gamble nonetheless.